Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Pharmaceutical Industry: Market Research Reports, Statistics and Analysis

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
26 reviews

The global pharmaceutical industry is a highly competitive industry that should be worth more than $1 trillion in 2014. (Photo: Pawel Kryj)

Global Pharmaceutical Industry


The global pharmaceutical industry is expected to be worth more than $1 trillion in 2014, marking a 5% compound annual growth rate according to research from Urch Publishing.

 

The industry is comprised of companies that make, patent and sell drugs that have therapeutic effect. The market is highly competitive and entry is difficult due to a combination of strict regulations and the need for extensive research and development, involving time-consuming clinical trials.

 

In addition, high research and development costs, lengthy clinical trial processes, expiring patents and difficulty in gaining product approval from the appropriate regulatory bodies all mean that companies must produce blockbuster drugs and continue to do so to remain in good standing.

 

Other challenges facing the industry include pressure from purchasers, such as hospitals, who negotiate discounts with wholesalers or manufacturers when buying in bulk – thereby increasing pressure on pharmaceutical companies to produce cost-effective drugs to remain competitive and gain approval for new drugs. According to the Center for Drug Evaluation and Research, on average there have been less than 23 approvals annually over the past decade. Industry observer Pharmalot states there was a fall in the number of applications for approval received by the US Food and Drug Administration from just fewer than 40 in 2009 to 23 in 2010.

 

Though patents protect the intellectual property rights of specific drugs, usually for approximately 20 years, pharmaceutical companies face increasing pressure related to generics, which are drugs comprised of the same ingredients as patented drugs but sold under a drug’s chemical name rather than the pharmaceutical brand name.

 

Medical professionals can prescribe drugs under their chemical name without specifying a brand. The pharmaceutical market spans a spectrum of drugs and medication, including prescription, generic and over-the-counter drugs. The scope also includes drug delivery technology, drug discovery and development, vitamins and supplements, pathology, therapeutics, and pharmacies and drug stores.

 

 

...
More »

You might be interested in: drug, clinical trial, medicine, more »

» View Public Reports

1-10 of about 14 000 reports

Global Pharmaceutical Sector Overview

  • Industry report
  • December 2013
  • 48 pages

... To eliminate maternal-to-child transmission of hiv and syphilis and the use of and performance of rapid dual hiv and syphilis tests professor jeffrey d. Klausner global health and infectious diseases ...

  • Industries: Pathology
  • Countries: World

U.S. Pharmaceutical Industry Analysis

  • Industry report
  • April 2014
  • 129 pages

... Of work are implicated as important causes of hypertension, as well as cvd., E.G. Job strain 96 schnall pl et al. Why the workplace and cardiovascular disease. In: schnall pl, belkic kl, landsbergis pa ...

  • Industries: Pathology
  • Countries: United States

Pharmaceutical in Europe : Innovation and Technology Trends

  • Industry report
  • January 2014
  • 17 pages
  • by Intergovernmental Agency
  • Industries: Pathology
  • Countries: Europe

Pharmaceutical in Japan and The United Kingdom : Innovation and Technology Trends

  • Industry report
  • December 2013
  • 22 pages
  • by Corporation

... arthritis diabetes high satisfaction with treatment diseases with high contribution from medications diabetes complication alzheimer's disease presence of unmet medical needs low ...

  • Industries: Pathology
  • Countries: Japan, World, United Kingdom

The French Pharmaceutical Industry Analysis

  • Industry report
  • September 2013
  • 53 pages

... And metabolic risk 1013 bacterias great diversity gut microflora is involved in ominal obesity and metabolic disorders nm delzenne microbial cell factories 2011 gut dyosis is involved in metabolic ...

  • Industries: Pathology
  • Countries: France

Pharmaceutical Key Market Figures in Germany

  • Industry report
  • June 2013
  • 27 pages

... Dialogues within the pharma industry germany pharmaceutical industry overview cphi, icse & p-mec china innovation and development forum main forum: policy and market june 25, 2013 ralf ...

  • Industries: Pharmaceutical
  • Countries: Germany

Pharmaceutical in China and Italy : Innovation and Technology Trends

  • Industry report
  • October 2012
  • 25 pages
  • Industries: Pharmaceutical
  • Countries: China, World, Italy

Pharmaceutical Market in The United Kingdom

  • Industry report
  • December 2013
  • 22 pages

... In england at record levels, rising by 20% in a decade, alcoholic liver disease (37%) of all liver disease deaths mental and behavioural disorders associated with alcohol use risen over the past 10 years ...

  • Industries: Pathology
  • Countries: United Kingdom

Pharmaceutical Sector in Canada

  • Industry report
  • March 2014
  • 31 pages

... T as ia & pac ific n. A frica & m iddl e ea st sub -sah aran afr ica e.Eu rop e & c. A sia w. E uro pe & u.S . The percent of people aged 40+ with no previous diagnosis of diabetes ...

  • Industries: Pathology
  • Countries: Canada

Pharmaceutical in Brazil : Innovation and Technology Trends

  • Industry report
  • October 2013
  • 24 pages
  • Industries: Pharmaceutical
  • Countries: World, South America, Brazil

» Purchase Premium Reports (From $ 55 - $ 12 375)

About 30 000 reports
Oncology Drug Pathway Analyzer (Premium Version)

Oncology Drug Pathway Analyzer (Premium Version)

  • $ 14 850
  • Industry report
  • March 2014
  • by Bioseeker

EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,400 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the critical ...

Insulin Aspart - Comprehensive Patent Search

March 2014 $ 10 500

Insulin Glargine - Comprehensive Patent Search

March 2014 $ 10 500

Insulin Lispro - Comprehensive Patent Search

March 2014 $ 10 500

Pharmapoint: Prophylactic Hepatitis B Virus Vaccines - ...

January 2014 $ 9 995

Pharmapoint: Type 2 Diabetes - Global Drug Forecast And ...

January 2014 $ 9 995

Pharmapoint: Crohn's Disease - Global Drug Forecast And ...

January 2014 $ 9 995

Dexmedetomidine - Comprehensive Patent Search

March 2014 $ 9 300

Lanreotide - Comprehensive Patent Search

March 2014 $ 9 300

Fludarabine - Comprehensive Patent Search

March 2014 $ 8 850

» Read our Company Profiles

About 200 Companies

EDGAR Online Inc.

United States

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

AccessEd

Australia

Pfizer Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.